sales-marketing improving-patient-engagement-and-drug-development-through-ai-and-enhanced-medical 
pharmaphorum
JANUARY 5, 2021
Anyone who proposed that a novel, deadly virus would spread, with a vaccine developed demonstrating 95% efficacy, and approved for patients in less than a year would have been scoffed at. The pharmaceutical industry has been through extraordinary times, and responded magnificently. Yet these things have happened.
PharmaShots
APRIL 3, 2023
Shots: The first quarter of 2023 highlights major acquisitions in the pharma and biotech industry along with multiple approvals. Meanwhile, Selecta and Sobi reported P-III trial (DISSOLVE I & II) results of SEL-212 for chronic refractory gout Starting with the latest acquisitions, Pfizer acquired Seagen for ~$43B.
Expert insights. Personalized for you.
105 
Let's personalize your content